Redmile Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-189,008
Closed -$28.7M 78
2017
Q3
$28.7M Buy
189,008
+44,600
+31% +$6.78M 1.42% 27
2017
Q2
$18.6M Buy
+144,408
New +$18.6M 1.13% 34
2013
Q4
Sell
-108,262
Closed -$8.21M 64
2013
Q3
$8.21M Buy
+108,262
New +$8.21M 1.24% 31